O

OssDsign AB
STO:OSSD

Watchlist Manager
OssDsign AB
STO:OSSD
Watchlist
Price: 8.05 SEK 1.26% Market Closed
Market Cap: 786.2m SEK
Have any thoughts about
OssDsign AB?
Write Note

OssDsign AB
Net Issuance of Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

OssDsign AB
Net Issuance of Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
O
OssDsign AB
STO:OSSD
Net Issuance of Common Stock
kr150m
CAGR 3-Years
32%
CAGR 5-Years
38%
CAGR 10-Years
N/A
Xvivo Perfusion AB
STO:XVIVO
Net Issuance of Common Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
D
Doxa AB
STO:DOXA
Net Issuance of Common Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bactiguard Holding AB
STO:BACTI B
Net Issuance of Common Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
V
Vimian Group AB
STO:VIMIAN
Net Issuance of Common Stock
€142.8m
CAGR 3-Years
40%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
S2Medical AB (publ)
STO:S2M
Net Issuance of Common Stock
kr742k
CAGR 3-Years
-70%
CAGR 5-Years
-57%
CAGR 10-Years
N/A
No Stocks Found

OssDsign AB
Glance View

Market Cap
786.2m SEK
Industry
Health Care

OssDsign AB is a holding company, which designs, manufactures, and sells implants and material technology for bone regeneration. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2019-05-24. The company aims at developing implantable products that respond to clinical challenges, with focus on bone healing. Its primary focus is skull surgery. The firm uses design solutions, material compositions and manufacturing processes mainly based on proprietary bioceramic technologies. The bioceramics it uses integrate with tissues and support bone ingrowth. OssDsign AB's main product is Craniomosaic, an implant for the repair of skull defects (cranioplasty). Along with it, the Company develops bioceramic implants for facial bone augmentation. The firm's customers include neurosurgeons, craniofacial and maxillofacial surgeons.

OSSD Intrinsic Value
10.3 SEK
Undervaluation 22%
Intrinsic Value
Price
O

See Also

What is OssDsign AB's Net Issuance of Common Stock?
Net Issuance of Common Stock
150m SEK

Based on the financial report for Dec 31, 2023, OssDsign AB's Net Issuance of Common Stock amounts to 150m SEK.

What is OssDsign AB's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
38%

Over the last year, the Net Issuance of Common Stock growth was 127%. The average annual Net Issuance of Common Stock growth rates for OssDsign AB have been 32% over the past three years , 38% over the past five years .

Back to Top